title: Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
abstract: Covalent linkage of immunostimulatory CpG DNA to OVA results in CpG DNA-aided cross-presentation of OVA by dendritic cells (DCs). In vivo, cross-presentation is conditional for cross-priming of OVA-specific CD8 T cells. In this study, we investigated the involvement of the CpG DNA receptor Toll-like receptor (TLR)9 in CpG DNA-aided cross-presentation and cross-priming. Although CpG DNA-aided cross-presentation is not altered in TLR9-deficient cells, TLR9 is required for maturation of APC allowing cross-priming, as resulting in CTL function. These findings imply that TLR9 does not trigger endocytosis of CpG-OVA conjugates, but activates DCs downstream of endocytosis.
authors.affiliation: Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany.
authors.forename: Antje
authors.initials: A
authors.lastname: Heit
authors.forename: Tobias
authors.initials: T
authors.lastname: Maurer
authors.forename: Hubertus
authors.initials: H
authors.lastname: Hochrein
authors.forename: Stefan
authors.initials: S
authors.lastname: Bauer
authors.forename: Katharina M
authors.initials: KM
authors.lastname: Huster
authors.forename: Dirk H
authors.initials: DH
authors.lastname: Busch
authors.forename: Hermann
authors.initials: H
authors.lastname: Wagner
mesh_terms: D000276:Adjuvants, Immunologic / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002460:Cell Line; D002478:Cells, Cultured; D018899:CpG Islands / Q000276:immunology; D004247:DNA / Q000276:immunology* / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D004705:Endocytosis / Q000276:immunology; D007114:Immunization; D018796:Immunoconjugates / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009838:Oligodeoxyribonucleotides / Q000276:immunology* / Q000378:metabolism; D010047:Ovalbumin / Q000276:immunology* / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000096:biosynthesis* / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism; D051217:Toll-Like Receptor 9
chemical_list: D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D004268:DNA-Binding Proteins; D018796:Immunoconjugates; D009838:Oligodeoxyribonucleotides; D011956:Receptors, Cell Surface; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9; D010047:Ovalbumin; D004247:DNA